Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials. - Wikidata - awgldk - TriplyDB

Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials.

Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials.

http://www.wikidata.org/entity/Q30783484

about

Toward precision medicine of breast cancer Implementing Genome-Driven Oncology.Integrated host and viral transcriptome analyses reveal pathology and inflammatory response mechanisms to ALV-J injection in SPF chickens Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value of for hepatocellular carcinoma patients.Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center.miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop.Sequencing Strategies to Guide Decision Making in Cancer Treatment.AfterQC: automatic filtering, trimming, error removing and quality control for fastq data.Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAF Rational design of cancer gene panels with OncoPaD.Comparing sequencing assays and human-machine analyses in actionable genomics for glioblastoma.Managing the genomic revolution in cancer diagnostics.Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence.Local recurrences at the anastomotic area are clonally related to the primary tumor in sporadic colorectal carcinoma The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples.Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy.Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.Genotyping of colorectal cancer for cancer precision medicine: Results from the IPH Center for Molecular Pathology.Oncologist use and perception of large panel next-generation tumor sequencing.Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research.Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.Metastatic solid tumors to the jaw and oral soft tissue: A retrospective clinical analysis of 44 patients from a single institution.Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy.Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancer.Quantifying the Benefits of Genome-Driven Oncology.Validation of Customized Cancer Panel for Detecting Somatic Mutations and Copy Number Alterations.Improved Pathologic Diagnosis-Forecasting the Future in Glioblastoma.Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy.The Mutational Landscape of Gastrointestinal Malignancies as Reflected by Circulating Tumor DNA.Precision oncology in the age of integrative genomics.Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay.Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patients.Treatment and outcome of adult-onset neuroblastoma.Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations.Precision Medicine in Head and Neck Cancer: Myth or Reality?Establishing and Maintaining an Extensive Library of Patient-Derived Xenograft Models.

P2860

Q28073967-93DB34F0-9605-4CA0-96B6-4D7A354AFB84 Q30235979-9DA5AFA3-0B3B-44E7-9CF4-55E0D24000F3 Q33555505-2BC8CF95-FB3A-4904-99B5-A5804D982428 Q33648502-1D650005-0435-4A90-9413-CA48C70BB4F8 Q33677392-C1A184E2-0A0A-4E5E-8D90-DF3495EE06F9 Q33804175-52332353-E44B-4A98-A2BD-7566A232AF70 Q33817011-7A443935-8658-4AA7-994C-1D9A6ACE5235 Q33872384-3C586B4B-704C-43A1-A443-06A47C9589B8 Q36214189-C69C7D87-6DC3-4D45-BA3D-5EC2AD8EB753 Q36329344-27A87299-4ACD-4F8F-BC3F-3A0CF7A7E341 Q37149773-BF41ED59-30DC-49F1-B0FE-08A646AD69F2 Q37305368-C255DEDC-320B-4B98-ACBA-B9162E2A5F30 Q38373381-01A52197-0F82-4F33-B622-0E4966AC044E Q38714606-45433DF4-0AB6-49D9-A035-AADC234B3D33 Q38716479-D36E871B-5C60-4281-B504-4712245F91AD Q38801883-DA15B63E-86D1-4CC9-890E-416789AF2C65 Q38904371-883D7FF8-189F-4CBE-B0CF-966B84BB4F1D Q39126105-64613771-331A-47FE-B9F6-2D1F9984376D Q39831543-D052D1A7-6E93-444B-8CAA-5EA13917B4B9 Q39884524-D8EDF34D-A607-406E-A3E9-FCAB7700F502 Q39934413-4D39D592-9305-4295-867E-BEEB44662419 Q39967039-CA1A449D-03AC-4F75-988E-D0DCCA3E6220 Q40040765-8BF76C16-84A8-4FAF-8DB6-A5F5B948E94B Q41107504-8BA13559-156F-4CEA-8034-34FB21A97D78 Q41981114-A7120EFA-2E36-417C-BE66-370BF04FD35A Q42326376-CADA014F-5886-499A-883D-C425247FA444 Q46007270-A76FF694-F666-4AE6-B9FA-8D611599FED3 Q47130626-32B2DCC9-3C92-40BF-9C66-A9A03494F2C3 Q47145498-D51B4841-F5AF-45A8-A9A4-09B6A8B910FB Q47201395-61FE0D3E-9D45-41B4-9426-34DFBCC40A2E Q47745264-2247E8E7-AAEA-43F5-8EA5-06602D91453B Q48156858-A1D242DD-C771-4209-A38A-60871CE535DB Q50042439-41B3EDFD-FC2E-4C63-919F-43DB418BEC34 Q50105699-3C840AB1-7108-4E15-9422-ACA24632C103 Q51232753-F76D4FE0-7AC2-407B-8AA1-EEA85CEC6F18 Q52587597-FDD9B360-B23B-45BC-B458-FFF360688F7E Q52637916-C860675F-80EA-48F3-8ED1-F076C3F7076A Q52673540-E267BD23-6331-4E4A-B7F8-9A617318A9A7 Q55012383-6821E427-6BBD-4EFB-874B-9EB8716B44CF Q55380373-63FE41BF-228A-43AE-AAC1-51E4264220AA

P2860

Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials.

http://www.wikidata.org/entity/Q30783484

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Precision medicine at Memorial ...... ation targeted therapy trials.

@ast

Precision medicine at Memorial ...... ation targeted therapy trials.

@en

type

label

Precision medicine at Memorial ...... ation targeted therapy trials.

@ast

Precision medicine at Memorial ...... ation targeted therapy trials.

@en

prefLabel

Precision medicine at Memorial ...... ation targeted therapy trials.

@ast

Precision medicine at Memorial ...... ation targeted therapy trials.

@en

P1433

Q30783484-C163C991-469F-4C47-AD1E-3AEADD75D297

P1476

Q30783484-553A2E1F-3903-4A1E-A66A-190BBF8FCE7C

P2093

Q30783484-175A05C7-E4F9-4C70-B9C1-ECD01F1AD8FE

Q30783484-256C4F9D-C759-4330-B498-246F60CDC378

Q30783484-385BEF16-37E2-401B-B722-97140D69D661

Q30783484-55984B43-5A0E-4A7F-AB9C-8EDC0908DF6B

Q30783484-6A53A57F-7E35-443B-A153-8C13F7ADEA4A

Q30783484-850B9D72-1B43-4CB3-A2DC-50DF6C836DC7

P2860

Q30783484-062A481C-1D63-4AD5-8956-4256FC0A3581

Q30783484-0BAA8EEE-1F91-4A40-86F9-CA98E1C1A847

Q30783484-2530911C-F9D7-4694-8101-8DE7B93710F1

Q30783484-26368AE5-A562-47B0-B9A1-1CC171928778

Q30783484-3A6940B8-60BA-4EC4-AA16-61C8A887BFF9

Q30783484-4FD5E5E3-83DE-4175-B782-BCF3ECDF9098

Q30783484-67A5834F-BEFC-4F1B-B881-8E4D47D434D7

Q30783484-86499D69-5BEF-4C79-96DD-F0E20CCFA773

Q30783484-8766DDE5-08A0-4F13-A668-AFDE0A0638A4

Q30783484-8C0DE8B3-D8E2-4700-B6DB-734638D45514

P304

Q30783484-DECB8B8B-C658-469B-8F2D-2C69B0E7AC93

P31

Q30783484-BE895609-100B-4CC2-970D-23C30D65D10E

P356

Q30783484-1B381E1F-9CF4-4960-8130-74A265CA8C02

P433

Q30783484-C34FB624-881E-4BA3-B964-563569E6E6EF

P478

Q30783484-7B9AB6F0-6C39-414E-A78D-B65DD1D9366C

P50

Q30783484-8C3B9651-6C2E-4B1C-A460-2FE499F7F8C7

Q30783484-D9ACB1EA-9F5A-4B1C-BE1C-99F042340A76

P577

Q30783484-04D87C10-5353-4A23-80CD-DA7993CFB1A9

P698

Q30783484-3347E042-2D85-4143-9DCD-B4234F08FACF

P932

Q30783484-3543D878-B238-4743-B925-9CDBE052B764

P356

J.DRUDIS.2015.08.005

P1433

Drug Discovery Today

P1476

Precision medicine at Memorial ...... ation targeted therapy trials.

@en

P2093

David B Solit

http://www.w3.org/2001/XMLSchema#string

David M Hyman

http://www.w3.org/2001/XMLSchema#string

Donavan T Cheng

http://www.w3.org/2001/XMLSchema#string

Maria E Arcila

http://www.w3.org/2001/XMLSchema#string

Michael F Berger

http://www.w3.org/2001/XMLSchema#string

Paul Sabbatini

http://www.w3.org/2001/XMLSchema#string

P2860

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Identification of targetable FGFR gene fusions in diverse cancers.

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

Crizotinib in ROS1-rearranged non-small-cell lung cancer.

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skipping

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

Age-related clonal hematopoiesis associated with adverse outcomes

P304

1422-1428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.DRUDIS.2015.08.005

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26320725

http://www.w3.org/2001/XMLSchema#string

P932

4940024

http://www.w3.org/2001/XMLSchema#string